Package | us.nlm.vsac |
Resource Type | ValueSet |
Id | 2.16.840.1.113762.1.4.1078.696 |
FHIR Version | R4 |
Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1078.696/expansion |
URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.696 |
Version | 20231024 |
Status | active |
Date | 2023-10-24T01:03:22-04:00 |
Name | Reclast |
Title | Reclast |
Realm | us |
Authority | hl7 |
Purpose | (Clinical Focus: Intravenous Reclast and generic zoledronic acid for human use),(Data Element Scope: DRUG_CLASS_MEMBERS: PHARMACOLOGIC:),(Inclusion Criteria: Prescribable forms of zoledronic acid.),(Exclusion Criteria: Invalid and non-prescribable forms.) |
No resources found
CodeSystem | |
rxnorm | RxNorm |
No narrative content found in resource
{ "resourceType": "ValueSet", "id": "2.16.840.1.113762.1.4.1078.696", "meta": { "versionId": "8", "lastUpdated": "2023-12-21T17:43:03.000-05:00", "profile": [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ] }, "extension": [ { "url": "http://hl7.org/fhir/StructureDefinition/valueset-author", "valueContactDetail": { "name": "Optum Author" } }, { "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate", "valueDate": "2023-10-24" }, { "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate", "valueDate": "2023-10-24" } ], "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.696", "identifier": [ { "system": "urn:ietf:rfc:3986", "value": "urn:oid:2.16.840.1.113762.1.4.1078.696" } ], "version": "20231024", "name": "Reclast", "title": "Reclast", "status": "active", "date": "2023-10-24T01:03:22-04:00", "publisher": "Optum Steward", "jurisdiction": [ { "coding": [ { "system": "urn:iso:std:iso:3166", "code": "US" } ] } ], "purpose": "(Clinical Focus: Intravenous Reclast and generic zoledronic acid for human use),(Data Element Scope: DRUG_CLASS_MEMBERS: PHARMACOLOGIC:),(Inclusion Criteria: Prescribable forms of zoledronic acid.),(Exclusion Criteria: Invalid and non-prescribable forms.)", "compose": { "include": [ { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "concept": [ { "code": "1114084", "display": "zoledronic acid 0.04 MG/ML" }, { "code": "1114085", "display": "100 ML zoledronic acid 0.04 MG/ML Injection" }, { "code": "1156253", "display": "zoledronic acid Injectable Product" }, { "code": "1178326", "display": "Reclast Injectable Product" }, { "code": "1546014", "display": "zoledronic acid anhydrous" }, { "code": "1865663", "display": "zoledronic acid 4 MG" }, { "code": "1865664", "display": "zoledronic acid Injection" }, { "code": "1865665", "display": "zoledronic acid 4 MG Injection" }, { "code": "1865680", "display": "zoledronic acid Injection [Reclast]" }, { "code": "351114", "display": "5 ML zoledronic acid 0.8 MG/ML Injection" }, { "code": "358826", "display": "zoledronic acid 0.8 MG/ML" }, { "code": "705823", "display": "zoledronic acid 0.05 MG/ML" }, { "code": "705824", "display": "100 ML zoledronic acid 0.05 MG/ML Injection" }, { "code": "705872", "display": "Reclast" }, { "code": "705873", "display": "zoledronic acid 0.05 MG/ML [Reclast]" }, { "code": "705875", "display": "100 ML zoledronic acid 0.05 MG/ML Injection [Reclast]" }, { "code": "77655", "display": "zoledronic acid" } ] } ] }, "expansion": { "identifier": "urn:uuid:f2fbfa69-f526-437c-b6c8-c5db734816ea", "timestamp": "2025-05-23T17:54:53-04:00", "total": 17, "contains": [ { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1114084", "display": "zoledronic acid 0.04 MG/ML" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1114085", "display": "100 ML zoledronic acid 0.04 MG/ML Injection" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1156253", "display": "zoledronic acid Injectable Product" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1178326", "display": "Reclast Injectable Product" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1546014", "display": "zoledronic acid anhydrous" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1865663", "display": "zoledronic acid 4 MG" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1865664", "display": "zoledronic acid Injection" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1865665", "display": "zoledronic acid 4 MG Injection" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1865680", "display": "zoledronic acid Injection [Reclast]" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "351114", "display": "5 ML zoledronic acid 0.8 MG/ML Injection" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "358826", "display": "zoledronic acid 0.8 MG/ML" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "705823", "display": "zoledronic acid 0.05 MG/ML" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "705824", "display": "100 ML zoledronic acid 0.05 MG/ML Injection" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "705872", "display": "Reclast" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "705873", "display": "zoledronic acid 0.05 MG/ML [Reclast]" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "705875", "display": "100 ML zoledronic acid 0.05 MG/ML Injection [Reclast]" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "77655", "display": "zoledronic acid" } ] } }